BenevolentAI Limited

Industry

  • Pharmaceuticals
    • Vaccines
  • Digital Health
    • Artificial Intelligence
  • Biotechnology
    • Drug Discovery Technologies

Other Names/Subsidiaries

  • BenevolentBio, BenevolentTech
See more in Biomedtracker

Latest on BenevolentAI Limited

Scrip

Isomorphic Adds To Growing AI War Chest With First External Funding Round

 
• By Alaric DeArment

Artificial intelligence-focused biotech Isomorphic Labs is getting another big infusion of funding to further develop its drug-design system and also to advance some of its programs into the clinic, o

Scrip

Asia Deal Watch: AstraZeneca Buys FibroGen’s Chinese Subsidiary

 
• By Joseph Haas, Vibha Ravi, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Deal Brings AstraZeneca Greater C

In Vivo

TechBio Investment Snapshot: Funding, Alliances And Collaboration

 
• By Jo Shorthouse

The number of financings among life sciences companies in the TechBio sector increased from Q3 2023, stabilizing in H1 2024. During the period Q3 2023 – Q3 2024, a total of $6bn was raised, with the s

Scrip

Beleaguered BenevolentAI Goes Back To Its Roots

 
• By Kevin Grogan

Back in the bosom of BenevolentAI, the company he founded in 2013, Ken Mulvany has announced “a major strategic overhaul” and substantial cost-cutting program to return the UK-based artificial intelli